AHA yesterday urged the Medicare Payment Advisory Commission to release a “more granular assessment of the hospital-level impacts” of its potential changes to the Indirect Medical Education program. At its September meeting, MedPAC commissioners discussed possible changes to the IME program, including shifting some IME funds to the outpatient setting; eliminating capital IME payments; and shifting some funds to a performance-based payment program. “While total aggregate IME funds would remain the same, MedPAC acknowledged that there would be ‘substantial distribution of IME payments’ and that many teaching hospitals would see ‘material changes’ in their IME payments,” AHA wrote. “This redistribution would also have significant impacts on hospitals’ total Medicare margins.” According to MedPAC’s March report to Congress, major teaching hospitals had an overall Medicare margin of negative 9.0% in 2017, the letter notes. “Exacerbating Medicare underpayments even further is untenable and would limit hospitals’ ability to provide state-of-the-art clinical care and train the next generation of practitioners,” AHA said.

Related News Articles

Headline
The AHA Sept. 17 urged the Department of Health and Human Services’ Office of Inspector General to further scrutinize policies and practices by certain…
Headline
The Centers for Medicare & Medicaid services Sept. 10 announced the opening of a 60-day public comment period regarding its proposed plan for new data…
Headline
Hospitals and health systems are seeing significant increases in administrative costs, including due to burdensome practices by commercial insurers that often…
Headline
The American Society for Health Care Risk Management Sept. 5 announced two AdventHealth hospitals in Florida will receive its 2024 Innovation Award.…
Headline
AHA Aug. 23 named James “Scott” Gee deputy national advisor for cybersecurity and risk. Gee will work with John Riggi, AHA’s national advisor for cybersecurity…
Headline
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices…